• Alaeus A, Lidman K, Björkman A, Giesecke J, Albert J (1999) Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. AIDS 13, 901 907.
  • CASCADE study (2000) Time from HIV-1 seroconversion to AIDS and death before widespread use of highly active antiretroviral therapy: a collaborative re-analysis. Lancet 355, 1131 1137.DOI: 10.1016/s0140-6736(00)02061-4
  • Coutinho RA (1998) The Amsterdam Cohort Studies on HIV infection and AIDS. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 17 (Suppl. 1), S4 S8.
  • Galai N, Kalinkovich A, Burstein R, Vlahov D, Bentwich Z (1997) African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel (letter). Lancet 349, 180 181.
  • van Haastrecht HJA, van Ameijden EJC, van den Hoek JAR, Mientjes GHC, Bax JS, Coutinho RA (1996) Predictors of mortality in the Amsterdam cohort of Human Immunodeficiency Virus (HIV) -positive and HIV-negative drug users. American Journal of Epidemiology 143, 380 391.
  • Kanki PJ, Hamel DJ, Sankalé J-L et al. (1999) Human Immunodeficiency Virus type 1 subtypes differ in disease progression. Journal of Infectious Diseases 179, 68 73.
  • Kaslow RA, Carringtom M, Apple R et al. (1996) Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Medicine 2, 405 411.
  • Keet IPM, Tang J, Klein MR et al. (1999) Consistent associations of HLA class I and II and transporter gene products with progression of Human Immunodeficiency Virus type 1 infection in homosexual men. Journal of Infectious Diseases 180, 299 309.
  • Koblin BA, van Benthem BHB, Buchbinder SP et al. (1999) Long-term survival after infection with Human Immunodeficiency Virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trials cohorts in Amsterdam, New York City and San Francisco, 1978–95. American Journal of Epidemiology 150, 1026 1030.
  • Morgan D, Maude GH, Malamba SS et al. (1997) HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 350, 245 250.DOI: 10.1016/s0140-6736(97)01474-8
  • Op de Coul ELM, Lukashov VV, van Doornum GJJ, Goudsmit J, Coutinho RA (1998) Multiple HIV-1 subtypes present amongst heterosexuals in Amsterdam 1988–96: no evidence for spread of non-B subtypes. AIDS 12, 1253 1255.
  • Prins M, Hernández Aguado I, Brettle RP et al. (1997) Pre-AIDS mortality form natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among drug users. AIDS 11, 1747 1756.
  • Prins M, Robertson JR, Brettle RP et al. (1999) Do gender differences in CD4 cell counts matter? AIDS 13, 2361 2364.
  • Prins M, Sabin CA, Lee CA, Devereux H, Coutinho RA (2000) Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men. AIDS 14, in press.
  • van Rij RP, de Roda Husman A-M, Brouwer M, Goudsmit J, Coutinho RA, Schuitemaker H (1998) Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI Human Immunodeficiency Virus type 1 infection and in the time to conversion to SI virus variants. Journal of Infectious Diseases 178, 1806 1811.
  • de Roda Husman A-M, Koot M, Cornelissen M et al. (1997) Association between CCR5 genotype and the clinical course of HIV-1 infection. Annals of Internal Medicine 127, 882 890.
  • Schinkel J, Langendam MW, Coutinho RA, Krol A, Brouwer M, Schuitemaker H (1999) No evidence for an effect of the CCR5, Δ32/+ and CCR2b 64I/+ mutations on Human Immunodeficiency Virus (HIV) -1 disease progression among HIV-1-infected injecting drug users. Journal of Infectious Diseases 179, 825 831.
  • Stewart G (1998) Chemokine genes-beating the odds. Nature Medicine 4, 275 277.